Is cystic fibrosis a TH17 disease?

被引：92

作者：

Dubin, P. J. ^{[1
]}

McAllister, F. ^{[1
]}

Kolls, J. K. ^{[1
]}

机构：

[1] Univ Pittsburgh, Childrens Hosp, Pittsburgh, PA 15213 USA

来源：

INFLAMMATION RESEARCH | 2007年 / 56卷 / 06期

关键词：

D O I：

10.1007/s00011-007-6187-2

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Cystic Fibrosis (CF) is the most common lethal genetic disease in the Caucasian population and typically results in the development of bronchial inflammation, bronchiectasis, the progressive loss of lung function and ultimately death. Recently it has been shown that products of the Th-17 subset of T-cells, specifically, IL-17A and IL-17F are elevated in the sputum of CF patients. This review will go over experimental evidence supporting a role for the IL- 23/IL-17 axis in CF lung inflammation.

引用

页码：221 / 227

页数：7

共 69 条

[1] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].

Bettelli, E ;

Carrier, YJ ;

Gao, WD ;

Korn, T ;

Strom, TB ;

Oukka, M ;

Weiner, HL ;

Kuchroo, VK .

NATURE, 2006, 441 (7090) :235-238

[2] New concepts of the pathogenesis of cystic fibrosis lung disease [J].

Boucher, RC .

EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (01) :146-158

[3] Overproduction of the CFTR R domain leads to increased levels of AsialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells [J].

Bryan, R ;

Kube, D ;

Perez, A ;

Davis, P ;

Prince, A .

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 19 (02) :269-277

[4] IL-10 controls Aspergillus fumigatus- and Pseudomonas aeruginosa-specific T-cell response in cystic fibrosis [J].

Casaulta, C ;

Schöni, MH ;

Weichel, M ;

Crameri, R ;

Jutel, M ;

Daigle, I ;

Akdis, M ;

Blaser, K ;

Akdis, CA .

PEDIATRIC RESEARCH, 2003, 53 (02) :313-319

[5]

DALEY L, 1985, J IMMUNOL, V134, P3089

[6] Update on pathogenesis of cystic fibrosis lung disease [J].

Donaldson, SH ;

Boucher, RC .

CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (06) :486-491

[7] Genetic modifiers of lung disease in cystic fibrosis [J].

Drumm, ML ;

Konstan, MW ;

Schluchter, MD ;

Handler, A ;

Pace, R ;

Zou, F ;

Zariwala, M ;

Fargo, D ;

Xu, AR ;

Dunn, JM ;

Darrah, RJ ;

Dorfman, R ;

Sandford, AJ ;

Corey, M ;

Zielenski, J ;

Durie, P ;

Goddard, K ;

Yankaskas, JR ;

Wright, FA ;

Knowles, MR .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (14) :1443-1453

[8]

DUBIN PJ, 2006, AM J PHYSL LUNG CELL

[9] A genome-wide association study identifies IL23R as an inflammatory bowel disease gene [J].

Duerr, Richard H. ;

Taylor, Kent D. ;

Brant, Steven R. ;

Rioux, John D. ;

Silverberg, Mark S. ;

Daly, Mark J. ;

Steinhart, A. Hillary ;

Abraham, Clara ;

Regueiro, Miguel ;

Griffiths, Anne ;

Dassopoulos, Themistocles ;

Bitton, Alain ;

Yang, Huiying ;

Targan, Stephan ;

Datta, Lisa Wu ;

Kistner, Emily O. ;

Schumm, L. Philip ;

Lee, Annette T. ;

Gregersen, Peter K. ;

Barmada, M. Michael ;

Rotter, Jerome I. ;

Nicolae, Dan L. ;

Cho, Judy H. .

SCIENCE, 2006, 314 (5804) :1461-1463

[10] ANTIBODIES FROM CHRONICALLY INFECTED CYSTIC-FIBROSIS PATIENTS REACT WITH LIPOPOLYSACCHARIDES EXTRACTED BY NEW MICROMETHODS FROM ALL SEROTYPES OF PSEUDOMONAS-AERUGINOSA [J].

FOMSGAARD, A ;

SHAND, GH ;

FREUDENBERG, MA ;

GALANOS, C ;

CONRAD, RS ;

KRONBORG, G ;

HOIBY, N .

APMIS, 1993, 101 (02) :101-112

← 1 2 3 4 5 6 7 →